Ironwood Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Ironwood Pharmaceuticals

05/05/2022 21:12

* Ironwood Pharmaceuticals Inc  IRWD.OQ  reported quarterly
adjusted earnings of 21 cents​​ per share for the quarter ended
in March. The mean expectation of five analysts for the quarter
was for earnings of 26 cents per share.
    * Revenue rose 9.8% to $97.53 million from a year ago; 
analysts
expected $94.36 million. 
    * Ironwood Pharmaceuticals Inc's reported EPS for the
quarter was
21 cents​.
    * The mean earnings estimate of analysts had risen by
about 2% in
the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Ironwood Pharmaceuticals Inc shares had fallen by 1.4%
this
quarter and gained 6.3% so far this year.
    * The company reported quarterly net income of $38.8
million.
    * Wall Street's median 12-month price target for Ironwood
Pharmaceuticals Inc is $13.50 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated May 5 at 08:12 p.m.  ​All
figures in US dollars unless otherwise stated